Introduction
============

The introduction of antibiotics into clinical practice almost 70 years ago was, without a shadow of a doubt, the greatest therapeutic change in medical history, significantly altering mortality and morbidity indicators related to infections. "Magical bullets" have long been considered the Holy Graal for healing infections, but time has shown that we were wrong ([@B100]).

Since the introduction of antibiotics, they have been used freely, with their prescription occurring almost always when they were not necessary. Recent data from the Centers for Disease Control and Prevention (CDC) shows that, 4 out of 10 children taken to a doctor's office with a common cold received antibiotics, certainly without necessity ([@B49]).

Since their introduction into clinical practice, almost 80 years ago, millions of tons of antibiotics have been produced and used, almost always prophylactically, in cleaning products, cosmetics, etc., The use in veterinary medicine is even more significant, corresponding to 75% of all the antibiotics produced in the American market ([@B33]). Beyond the exaggerated clinical use in children, we are still exposed to significant amounts of antibiotics in the water we drink ([@B28]; [@B99]; [@B4]; [@B93]) and even before we are born. A Danish study evaluated about one million of pregnant women and about one-third of them were exposed to one or more systemic treatments with antibiotics during their gestational period ([@B13]).

[@B23], in an important study published in 2015, evaluating almost 70% of all pharmaceutical prescriptions made in 2010 in the United States; show that American children, on average up to 2 years of age, received three full medications with antibiotics. Ten full antibiotic medications up to 10 years and around 17 full antibiotic medications until they turned 20 years of age ([@B23]).

Despite both the abundant literature and information on the inefficacy of antibiotics in fighting viral infections, studies continue to show that the use of antibiotics in combating viral respiratory infections remains high. [@B30] evaluated ca. 55000 visits of physicians by patients, presumably with ARTI (acute respiratory tract infections). The results showed that 49% of the patients with ARTI received prescriptions containing antibiotics; 8.9% of the patients received within 28 days a second prescription containing one antibiotic, and an astonishing 0.7% of the patients received a prescription with a third antibiotic to treat a viral infection ([@B30]).

In a study published in Japan, the authors investigated almost 25,000 medical appointments related to upper respiratory tract infections, with no indication of bacterial etiology. The authors reported that antibiotics were prescribed in 60% of the appointments, with third-generation cephalosporins predominating among the antibiotics prescribed for these infections of viral etiology ([@B41]).

In a study published in 2014, the authors showed that more than half (51%) of the patients with cough/cold diagnoses received antibiotic prescriptions by general practitioners in the United Kingdom in the year 2011. Using the same methodology, the authors of the study demonstrated that in 1999 such percentage was much lower (36%) ([@B40]).

Despite all the scientific literature, as well as International associations such as the World Health Organization, being emphatic in the guidelines for decreasing the number of antibiotic prescriptions and, when necessary, prescribing them in a more rational way ([@B20]), the numbers and studies continue to show an exaggerated use of these medicines, especially in children.

The other major form of contact we have had with antibiotics, now unintentionally, is with the large amount of these drugs both in the environment and in our food.

It is well known that the use of antibiotics in the production of animal proteins (cattle, pigs, and chickens) has been taking place since the 1940s, dumping thousands of tons of antibiotics into the feed of these animals. In the 1940s, Moore et al. published an article stating that sulfadiazines and aminoglycosides could increase the weight of chickens when incorporated into their diet. These authors concluded that "sulfasuxidine and streptomycin, single or in combination, lead to increased growth responses in chicks receiving our basal diet supplemented with adequate amounts of folic acid" ([@B61]).

The use of these antibiotics increases the conversion of feed into weight in these animals. The increase in weight of the treated animals may reach from 8 to 15% ([@B15]).

For a long time, the increase in both weight and size of animals treated with antibiotics added to their diet was attributed to the decrease in the appearance of subclinical infections, which would favor their growth ([@B12]; [@B38]; [@B26]; [@B31]). In fact, what happens is a phenomenon called dysbiosis, characterized by the significant alteration of the intestinal microbiota of these animals, favoring the predominance of microorganisms with greater capacity of metabolization of foods which, as a consequence, will provide a higher amount of calories to the animal, favoring its increase in weight, especially fat ([@B69]; [@B85]; [@B59]). It is important to remember that the classes of antibiotics most used to promote growth in animals are tetracyclines, macrolides, and penicillins, the very same classes used in human beings.

These antibiotics, in small amounts, reach humans either via consumption of the meat of these animals or by the immense amount of such drugs deposited in the soil. The Food and Drug Administration reported that, in 2011, 13500 tons of antibiotics were used for the production of animal proteins through raising cattle, poultry and pigs ([@B73]). Taking into account that ca. 75% of these antibiotics administered to animals are not absorbed, being eliminated via feces and urine, there are around 10 million kilograms of antibiotics dumped annually into the environment only by the feces and urine of these animals ([@B18]). It is important to remember that antibiotics also reach the environment via spraying of crops ([@B58]), as well as via hospital wastewaters and overdue medicines that reach our rivers, contaminating the public water supply with small, yet detectable, concentrations of antibiotics ([@B50]; [@B83]).

At a planetary scale, these numbers are even more worrying. Data from *The State of the World's Antibiotics 2015* allows to conclude that out of a total of 100000 tons of antibiotics produced worldwide, 65000 tons were used in animal production ([@B81]).

By making a rough calculation, estimating the world population at 7.2 billion human beings ([@B96]) and a worldwide production of antibiotics in the order of 100000 tons (10^11^ g), one obtains as a final result the absurd value of 13.8 g of antibiotic produced per year per inhabitant of our planet.

The exposure to agents that alter our microbiota has increased significantly in the last 80 years, whether as the form of treatments or prophylaxis, or even indirectly via consumption of foodstuff contaminated with these molecules, or even via the immense quantities dumped annually into our environment.

There is no doubt that our microbiota, exposed to 80 years of aggressions through antibiotics, is quite different from the microbiota of our grandparents and our ancestors ([@B10]).

Certainly, with a microbiota quite different from that of our ancestors, we have been metabolizing and utilizing our food during the digestive process in a very different way than we did hundreds (or even thousands) of years ago. Are there consequences of this?

Human Microbiota and Its Role
=============================

The human microbiota (called flora, until recently), especially the gut microbiota, has been the subject of hundreds of research studies aiming at shedding light on its role, its composition and the relationships that it establishes with its host ([@B3]; [@B29]; [@B48]; [@B60]; [@B86]).

The intestinal microbiota is composed by ca. 100 trillion cells, including bacteria, fungi, viruses and other eukaryotic species. There are basically five major Phyla: *Firmicutes*, *Bacteroidetes*, *Proteobacteria*, *Verrucomicrobia*, and *Actinobacteria* ([@B98]). The amount of microorganisms present in the human microbiota exceeds by more than 10 times the number of human cells integrating the human body ([@B36]), and the genes carried by these trillions of microorganisms (called "microbioma") surpass by more than 100 times the human genome, bringing a symbiotic relationship and of co-existence between the human host and his "guests" ([@B76]).

During our intrauterine life, our gastrointestinal tract is totally devoid of microbial life (and thus, practically sterile), although some authors claim that upon swallowing amniotic fluid by the fetus there would be the possibility of forming an intestinal "intrauterine" microbiota ([@B27]). The microbiota is established by contact. Children born via cesarean birth are, however, deprived of such contact, not contaminating themselves with the mother's microbiota ([@B54]).

The human microbiota begins to develop from birth, by vertical transmission, upon contact of the baby with both the vaginal, fecal and cutaneous microbiota, and exposure to breast milk ([@B72]). It develops with the contact with other family members, also suffering interference from the diet ([@B7]), age ([@B1]), sex([@B56]), and geographical location ([@B39]), and suffering also chemical and/or biological interference arising from exposure to antibiotics or probiotics. These interferents alter the microbiota most strongly until late childhood (3 years of age), time at which it stabilizes for the adult life ([@B90]).

The intestinal microbiota exerts numerous known functions: **(a)** trophic effect upon the intestinal epithelium, favoring the appearance of microvilli, which increases the capacity of nutrient absorption; **(b)** contributes to the homeostasis of the local immune system ([@B82]); **(c)** acts on the metabolization of indigestible polysaccharides, favoring the absorption of short chain fatty acids (SCFA) ([@B89]); and **(d)** regulates the intestinal transit, affecting the amount of energy absorbed from the diet ([@B92]). All these functions, especially those related to metabolism and absorption, clearly show the fundamental role that the human microbiota exerts on its host's weight gain or loss.

Due to having established structure and organic functions, numerous authors already consider the human intestinal microbiota as a new (invisible) organ ([@B21]; [@B68]; [@B36]; [@B67]). [@B87] compared the weight of the human microbiota (1.5 kg) with other organs such as liver (1.5 kg), brain (1.4 kg), lung (0.84 kg), and kidney (0.27 kg), thus shedding light upon the importance that this new (although invisible) organ represents to the human organism.

Human Microbiota and Metabolism
===============================

One of the major (and perhaps the most important) functions played by the intestinal microbiota is the metabolism of nutrients. In order to exert their function of withdrawing energy from the foodstuff consumed by their hosts, the microbiota produces enzymes such as glycoside hydrosilases and polysacharide lyases with the role of withdrawing energy from inaccessible foods ([@B94]).

The role of the microbiota in the uptake of energy from food, by transforming it into absorbable fat, has been elucidated in a more convincing manner by studies using germ-free animals. Regular animals, with normal microbiota, subjected to the same diet as their "germ-free" counterparts, accumulated more fat when compared to each other, contributing to the accumulation of fat in the former animals. The authors concluded their study by stating that "*Our findings suggest that the gut microbiota is an important environmental factor that affects energy harvest from the diet and energy storage in the host*" ([@B6]).

Indigestible oligosaccharides, such as oligofructose (inulin), are converted by the gut microbiota into monosaccharides which are then converted to SCFA (acetate, propionate, and butyrate), being then easily absorbed ([@B94]). The acetate and propionate formed are used by the liver for lipogenesis and gluconeogenesis. Butyrate has its role as energy source for colonic epithelial cells ([@B43]). The conversion of polysaccharides by microorganisms from the gut microbiota into SCFAs has been implicated as the factor responsible for the increased uptake of fat and concomitant obesity in human hosts ([@B37]; [@B97]).

For many years obesity has been treated as a pandemic, with constant increases in the prevalence among adolescent and children, being considered a real threat to the human condition.([@B44]) Worldwide, there are more than 2 billion individuals considered to be overweight or obese. The prevalence rate for these conditions increased 27.5% for adults and 47.1% for children between 1980 and 2013 ([@B66]).

The condition of obesity originates in multifactorial situations, including genetic ([@B91]), physiological (leptin modulation) ([@B9]), heredity ([@B32]), socio-cultural behaviors among populations; such as geography, food preferences, physical activity, gender, age, etc ([@B95]).

Over the last few years, and because of all the personal and public health disorders caused by obesity, numerous studies have been published showing the relevant role of the gut microbiota in the development of obesity ([@B72]; [@B101]; [@B77]; [@B11]; [@B14]; [@B23]; [@B29]; [@B42]; [@B71]).

Some studies relate the change in the proportion of the phyla Firmicutes:Bacteroidetes as responsible for the change of weight gain/loss. Such studies indicate that the increase of the phylo Firmicutes in relation to the Bacteroidetes would be responsible for the increase in the absorption of calories from food, supplying larger amounts of fat to the host with concomitant increase in both its weight and fat mass ([@B52]; [@B22]; [@B47]; [@B51]; [@B74]; [@B80]).

In this way, any disturbance in the microbiota (dysbiosis) may alter the Firmicutes:Bacteroidetes ratio, leading to a higher amount of Firmicutes and concomitant higher absorption of fats, increasing both the weight and the amount of fat of the host. These microbiota changes (dysbiosis) are caused by treatments with antibiotics, especially when administered before the first 3 years of life, even in small amounts and during short periods of time ([@B73]; [@B53]; [@B29]; [@B42]).

Antibiotics and Obesity
=======================

Results from controlled epidemiological studies carried out in the last 6 years (see Table [1](#T1){ref-type="table"}) involving 368360 children (sum of all studies) have always associated early-life (or even intrauterine) exposure to antibiotics with weight gain or BMI increase. It is important to emphasize that such association relates not the use of the antibiotic directly with obesity, but rather the antibiotic being the cause of the alteration of the microbiota (dysbiosis) and concomitant increase in the energy intake from the diet and consequent obesity.

###### 

Epidemiological studies in children in the last 6 years, showing the relationship between the use of antibiotics and obesity.

  Title of the study                                                                                                                                         Year   Subjects of the study      Final result(s) gathered                                                                                                                    Reference
  ---------------------------------------------------------------------------------------------------------------------------------------------------------- ------ -------------------------- ------------------------------------------------------------------------------------------------------------------------------------------- -----------
  Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics.   2011   28354 mother-child         Antibiotics in infancy influences the risk of overweight in later childhood                                                                 [@B2]
  Infant antibiotic exposures and early-life body mass.                                                                                                      2013   11532 children             Exposure to antibiotics during the first 6 months of life was associated with increases in body mass.                                       [@B88]
  Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study.                                         2014   74946 children             Exposure to antibiotics during the first 12 months of life is associated with a small increase in BMI in boys aged 5--8 years               [@B65]
  Infant antibiotic exposure and the development of childhood overweight and central adiposity                                                               2014   1047 children              Antibiotic use in the first year of life was associated with overweight                                                                     [@B5]
  Association of antibiotics in infancy with early childhood obesity.                                                                                        2014   64580 children             Repeated exposure to broad-spectrum antibiotics was associated with early childhood obesity                                                 [@B8]
  Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity.                                                                          2015   436 mother-child dyads     Exposure to antibiotics in the second or third trimester of pregnancy were associated with higher risk of childhood obesity.                [@B63]
  Prenatal exposure to systemic antibacterials and overweight and obesity in Danish schoolchildren: a prevalence study.                                      2015   9886 children              Prenatal exposure to systemic antibacterials was associated with an increased risk of overweight and obesity at school age                  [@B62]
  Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life.                                                                2015   6114 boys and 5948 girls   Antibiotic exposure before 6 months was associated with increased body mass                                                                 [@B75]
  Early Life Antibiotic Exposure and Weight Development in Children.                                                                                         2016   979 children               Repeated exposure to antibiotics early in life, especially β-lactam agents, is associated with increased weight and height.                 [@B57]
  Antibiotic Use and Childhood Body Mass Index Trajectory.                                                                                                   2016   142824 children            Body Mass Index increase                                                                                                                    [@B78]
  Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity.                                                         2016   21714 children             Administration of 3 or more courses of antibiotics before age of 2 years was associated with an increased risk of early childhood obesity   [@B79]
                                                                                                                                                                                                                                                                                                                                           

Studies in germ-free animals that received a microbiota transplant and did not receive any antibiotics whatsoever, developed obesity without contact with antibiotics, thus proving that gut microbiota plays a fundamental role in the accumulation of fat. The antibiotic serves only to alter it ([@B6]; [@B89]; [@B35]; [@B46]; [@B24]; [@B34]). Studies carried out using regular animals (non-germ-free) that received antibiotics point to the same direction, increasing the weight of the animals due to changes in their gut microbiota ([@B19]; [@B25]; [@B45]; [@B55]).

The relationship between the use of antibiotics and the development of obesity has become increasingly more evident and apparent in human beings. Some authors have clearly established the relationship between the use of antibiotics in large-scale in the past 70 years and the "epidemic" of obesity that has occurred in parallel, almost as an adverse epidemiological effect ([@B84]; [@B70]; [@B73]).

Data gathered from the CDC on Antibiotic Prescriptions Dispensed in United States. Community Pharmacies per 1000 inhabitants in 2014 show, on average, 835 antibiotic prescriptions dispensed per 1000 inhabitants ([@B16]). Such data, separated for the 50 individual American states, was compared with the obesity indicators of those same states (data also provided by the CDC) ([@B17]). The data on antibiotic prescriptions (n/1000 people) and indication of obesity (%) are displayed and compared in Table [2](#T2){ref-type="table"}.

###### 

Percentage of obesity and antibiotic prescription rate in all American States. Data from 2014, sourced from the Centers for Disease Control and Prevention (CDC).

                               Antibiotic prescription/   Antibiotic
  ---------------- ------ ---- -------------------------- ------------
  Louisiana        36.2   1    1177                       4
  Alabama          35.6   2    1124                       7
  Mississippi      35.6   3    1222                       3
  West Virginia    35.6   4    1285                       1
  Kentucky         34.6   5    1262                       2
  Arkansas         34.5   6    1155                       6
  Kansas           34.2   7    992                        10
  Oklahoma         33.9   8    966                        11
  Tennessee        33.8   9    1162                       5
  Missouri         32.4   10   936                        15
  Texas            32.4   11   899                        21
  Iowa             32.1   12   1001                       9
  South Carolina   31.7   13   927                        16
  Nebraska         31.4   14   1045                       8
  Indiana          31.3   15   951                        13
  Michigan         31.2   16   925                        17
  North Dakota     31     17   853                        26
  Illinois         30.8   18   853                        25
  Georgia          30.7   19   841                        28
  Wisconsin        30.7   20   745                        34
  South Dakota     30.4   21   901                        19
  North Carolina   30.1   22   861                        24
  Oregon           30.1   23   570                        49
  Maine            30     24   720                        37
  Pennsylvania     30     25   886                        23
  Alaska           29.8   26   502                        50
  Ohio             29.8   27   965                        12
  Delaware         29.7   28   938                        14
  Virginia         29.2   29   799                        29
  Wyoming          29     30   778                        32
  Maryland         28.9   31   796                        30
  New Mexico       28.8   32   714                        38
  Idaho            28.6   33   693                        42
  Arizona          28.4   34   740                        35
  Florida          26.8   35   729                        36
  Nevada           26.7   36   709                        40
  Washington       26.4   37   600                        47
  New Hampshire    26.3   38   702                        41
  Minnesota        26.1   39   710                        39
  Rhode Island     26     40   893                        22
  New Jersey       25.6   41   903                        18
  Connecticut      25.3   42   847                        27
  Vermont          25.1   43   639                        45
  New York         25     44   900                        20
  Utah             24.5   45   783                        31
  Massachusetts    24.3   46   769                        33
  California       24.2   47   570                        48
  Montana          23.6   48   648                        43
  Hawaii           22.7   49   644                        44
  Colorado         20.2   50   625                        46
                                                          

The results displayed in Table [2](#T2){ref-type="table"} exhibit a great similarity between the use of antibiotics in the United States and the indicators of obesity. When Pearson's correlation coefficient is applied, a result of 0.76 is obtained which is considered a positive and strong correlation, meaning that the higher the use of antibiotics the higher the rate of obesity at that place ([@B64]). The indexes of obesity ([@B17]) and of use of antibiotics ([@B16]) are plotted in Figure [1](#F1){ref-type="fig"}.

![American maps showing rates of obesity **(A)** and prescription of antibiotics **(B)** in the American States. Data from 2014, sourced from the Centers for Disease Control and Prevention (CDC).](fphar-09-01408-g001){#F1}

In the same way, however, by illustrating the data in a graphical fashion one can perceive much similarity between the data on obesity and the use of antibiotics, shown on the maps of the United States (see Figure [2](#F2){ref-type="fig"}).

![Correlation between the antibiotic prescription rates (per 1000 inhabitants) and indicators of obesity (%). Data from 2014, sourced from the CDC.](fphar-09-01408-g002){#F2}

Conclusion
==========

The answer to the title of this short review paper seems to be YES. The scientific community has reached a consensus on the relationship between antibiotics and obesity, showing beyond any doubt that the use of antibiotics causes dysbiosis to varying degrees, especially in children (with less than 3 years of age), which can trigger an increased energy intake from the diet with concomitant increase of weight.

There is no doubt whatsoever that antibiotics have been, and still are, drugs with vital importance in the fight against bacterial infections. However, the need for prudent and rational use of antibiotics is more and more clear so as to avoid both collective health problems (increase in bacterial resistance to these antimicrobial drugs) and individual health problems (increase in weight).

The alternative for replacing the microbiota with probiotics seems to be an important strategy for the safe use of antibiotics to fight bacterial infections in children, without the associated risk of dysbiosis and concomitant increase in body weight.

It is the vital role of the health-care professionals to orient both themselves and their patients toward the correct and prudent use of antibiotics, and to wait until further scientific studies enlighten even more the relationship between antibiotics, dysbiosis, and obesity.
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